Dong-A signs DA-9701 export deals

Published: 2011-04-01 06:58:00

Updated: 2011-04-01 06:58:00

Dong-A Pharmaceutical Co. said Wednesday that it has inked a memorandum of understanding with Pahang (Malaysia) and Landson (Indonesia) for its in-house developed DA-9701, a new prokinetic agent formulated with Pharbitis Semen and Corydalis Tuber.

The terms and conditions of the deal have yet to be finalized, but the two foreign companies are likely to granted exclusive rights to market DA-...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.